You are here: Home » Reuters » News
Business Standard

Insight: Toxin at heart of drug recall shows holes in medical safety net


By Alexandra Harney and Ben HirschlerSHANGHAI/LONDON (Reuters) - A toxin inadvertently produced in the manufacture of a widely prescribed medicine but not spotted for years raises questions about regulators' ability to detect risks in a sprawling global drug supply chain increasingly reliant on factories in China.China's Zhejiang Huahai Pharmaceutical, which produces bulk ingredients for drugmakers, told its customers in late June it had found NDMA in its valsartan, an off-patent blood pressure drug originally developed by Novartis.The discovery means that some of the 10 billion pills ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Wed, August 22 2018. 18:28 IST